CLINICAL_TRIALS
trial_result
· 2015-06-15
Clinical Trial Update: MK0767 in Type 2 Diabetes (0767-012) [Phase 2]
Summary
A Phase 2 trial of MK0767 for Type 2 Diabetes Mellitus was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: TERMINATED